Regenerative Medicine Market Research Report-Forecast To 2027

Regenerative Medicine Market information, By Material (Synthetic Materials, Genetically Engineered Materials, Pharmaceuticals), By Therapy (Stem Cell Biology, Cellular Therapy, Tissue Engineering), By Application (Cord Blood, Oncology, Urology, Orthopedics, Neurology, Dermatology) - Forecast till 2027

ID: MRFR/Pharma/1649-HCR | February 2021 | Region: Global | 80 pages

Regenerative Medicine Market Synopsis:

Market Scenario:

Regenerative Medicine Market is growing steadily. Factors that influence the regenerative medicine market are increasing advancement in healthcare technology, increasing advance technology in regenerative medicine market, increasing prevalence of chronic diseases, increasing growth in stem cell technology and others.Market for regenerative medicine is expected to reached 17.4 Billion from during the forecast period and grow at the rate of about 25.5% from 2020 to 2027.

Study objectives of the Market:

  • Providing detail analysis of the market structure along with forecast for the next 7 years of various segments and sub-segments of the Regenerative medicine global market.

  • Giving insights about factors affecting the market growth.

  • Analyzing the market based on various factors- price analysis, supply chain analysis, Porters Five Force analysis etc.

  • Giving the past revenue and predicted future revenue of the market segments and sub-segments with respect to the main market and various markets globally.

  • Giving regional level analysis of the market with respect to the current market size and future prospective.

  • Giving regional level analysis of the market with respect to segments, application, material and market’s sub-segments.

  • Providing an overview of key players and their strategic profiling in the regenerative medicine market, comprehensively analyzing their core competencies and drawing a competitive structure of the market.

  • Tracking and analyzing competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments in the Regenerative medicine market.



Key Players:                                          

Some of the key players in this regenerative medicine market are: Cook Biotech, Osiris Therapeutics, Organogenesis,  Stryker and RTI surgical, Baxter International, Inc., LifeSciences, Advanced Cell Technology, CryoLife, Sanofi, BioMimetic Therapeutics, StemCellsInc, Medtronic, LifeCell Kinetic Concepts and others. 


Global regenerative medicine market has been segmented on the basis of material which comprises synthetic materials, genetically engineered materials, pharmaceuticals, biologically derived materials and others. On the basis of therapy the market is segmented into stem cell biology, cellular therapy, tissue engineering and others. Furthermore on the basis of application the market is segmented into cord blood, oncology, urology, orthopedics, neurology, dermatology, cardiovascular, orthopedic and others.

Regional Analysis:                                           

Globally North America is the largest market for regenerative medicine market. North America holds the largest market share of more than 44% of the regenerative medicine global market and is expected to grow at a CAGR of 22.3%. Europe is the second-largest market for Regenerative medicine which is expected to grow at a CAGR of 22.5%. Asia pacific region is expected to be fastest growing region in regenerative medicine market.  

By Region

  • North America

    • US

    • Canada

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • China

      • Japan

      • India

      • Australia

      • South Korea

      • Rest of Asia-Pacific

  • Rest of the World

    • Middle East

    • Africa

    • Latin America

The report for regenerative medicine market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected regenerative medicine market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Intended Audience

  • Regenerative medicine manufacturers & suppliers

  • Biotechnology companies

  • Pharmaceutical companies

  • Hospitals

  • Clinics

  • Academic research institutes

  • Government institutes

Report Scope:
Report Attribute/Metric Details
  Market Size   2027: 17.4 Billion
  CAGR   2020-2027: 25.5%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Material, Therapy, Application
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Cook Biotech, Osiris Therapeutics, Organogenesis, Stryker and RTI surgical, Baxter International, Inc., LifeSciences, Advanced Cell Technology, CryoLife, Sanofi, BioMimetic Therapeutics, StemCellsInc, Medtronic, LifeCell Kinetic Concepts
  Key Market Opportunities   Research and developments
  Key Market Drivers

  • Increasing advancement in healthcare technology
  • Increasing advance technology
  • Increasing prevalence of chronic diseases
  • Increasing growth in stem cell technology

  • Frequently Asked Questions (FAQ) :

    The global regenerative medicine market is projected grow at approximately 25.5% CAGR during the assessment period (2020-2027).

    Increasing incidences of degenerative diseases and shortage of organs for transplantation and increasing utilization of nanomaterials in wound care, drug delivery, and immunomodulation are the major tailwinds pushing the growth of the global regenerative medicine market.

    North America holds the largest share in the global regenerative medicine market, followed by Europe and the Asia Pacific, respectively.

    Osiris Therapeutics, Inc. (US), Organogenesis Inc. (US), Vericel Corporation (US), NuVasive, Inc. (US), Stryker Corporation (US), Medtronic (Ireland), Integra LifeSciences (US), Acelity (KCI Concepts) (US), Cook Biotech Inc. (US), RTI surgical (US), C.R. Bard (US), Baxter International, Inc. (US), CryoLife (US), Advanced Cell Technology (US), Sanofi (France), StemCells Inc. (US), BioMimetic Therapeutics (US), and LifeCell Kinetic Concepts (US), are some of the major players operating in the regenerative medicine market.

    Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global regenerative medicine market adopt to gain a larger competitive advantage.

    Table of Contents

    1 Introduction

    1.1 Definition

    1.2 Scope of Study

    1.3 Research Objective

    1.4 Assumptions & Limitations

    1.5 Market Structure:

    2 Research Methodology

    2.1 Research Process

    2.2 Primary Research

    2.3 Secondary Research

    3 Market Dynamics

    3.1 Drivers

    3.2 Restraints

    3.3 Opportunities

    3.4 Challenges

    3.5 Macroeconomic Indicators

    4 Market Factor Analysis

    4.1 Porter’s five forces model

    4.1.1 Bargaining Power of suppliers

    4.1.2 Bargaining Power of Customer

    4.1.3 Intensity of Competitor’s

    4.1.4 Threat of New Entrants

    5 Global Regenerative medicine Market, by material

    5.1 Introduction

    5.1.1 Synthetic Materials

    5.1.2 Genetically Engineered Materials

    5.1.3 Biologically Derived Materials

    5.1.4 others

    6. Global Regenerative medicine Market, by Therapy

    6.1 Introduction

    6.1.1 Stem Cell Biology

    6.1.2 Cellular Therapy

    6.1.3 Tissue Engineering

    6.1.4 Others

    7. Global Regenerative medicine Market, by Application

    7.1 Introduction

    7.1.1 Cord Blood

    7.1.2 Oncology

    7.1.3 Urology

    7.1.4 Orthopedics

    7.1.5 Neurology

    7.1.6 Dermatology

    7.1.7 Cardiovascular

    7.1.8 Orthopedic

    8 Global Regenerative medicine Market, by regions

    8.1 Introduction

    8.1.1 North America US Canada

    8.1.2 Europe Germany France UK Italy Spain Rest of Europe

    8.1.3 Asia Pacific Japan China India Republic of Korea Rest of Asia Pacific

    8.1.4 Latin America, Middle East & Africa

    9 Company Landscape

    9.1 Introduction

    9.1.1 Mergers Acquisitions

    9.1.2 Collaborations

    9.1.3 Release/New Product Launches

    9.1.4 Other (Expansion, Updates, Partnership)

    10 Company Profile

    10.1 Cook Biotech.

    10.1.1 Company Overview

    10.1.2 Product/Business Segment Overview

    10.1.3 Financials

    10.1.4 Key Developments

    10.2 Baxter International, Inc

    10.2.1 Overview

    10.2.2 Product/Business Segment Overview

    10.2.3 Financials

    10.2.4 Key Developments

    10.3 Sanofi

    10.3.1 Overview

    10.3.2 Product/Business Segment Overview

    10.3.3 Financials

    10.3.4 Key Developments

    10.4 BioMimetic Therapeutics

    10.4.1 Overview

    10.4.2 Product/Business Segment Overview

    10.4.3 Financials

    10.4.4 Key Developments

    10.5 StemCellsInc

    10.5.1 Overview

    10.5.2 Product/Business Segment Overview

    10.5.3 Financials

    10.5.4 Key Developments

    10.6 Medtronic.

    10.6.1 Overview

    10.6.2 Product/Business Segment Overview

    10.6.3 Financials

    10.6.4 Key Developments

    10.7 LifeCell Kinetic Concepts

    10.7.1 Overview

    10.7.2 Product/Business Segment Overview

    10.7.3 Financials

    10.7.4 Key Developments

    10.8 RTI surgical

    10.8.1 Overview

    10.8.2 Product/Business Segment Overview

    10.8.3 Financials

    10.8.4 Key Developments

    10.9 Integra LifeSciences

    10.9.1 Overview

    10.9.2 Product/Business Segment Overview

    10.9.3 Financials

    10.9.4 Key Developments

    10.10 Advanced Cell Technology

    10.10.1 Overview

    10.10.2 Product/Business Segment Overview

    10.10.3 Financials

    10.10.4 Key Developments

    10.11 Organogenesis

    10.11.1 Overview

    10.11.2 Product/Business Segment Overview

    10.11.3 Financials

    10.11.4 Key Developments

    10.12 CryoLife

    10.12.1 Overview

    10.12.2 Product/Business Segment Overview

    10.12.3 Financials

    10.12.4 Key Developments

    10.13 Osiris Therapeutics

    10.13.1 Overview

    10.13.2 Product/Business Segment Overview

    10.13.3 Financials

    10.13.4 Key Developments

    11 Appendix